Skip to main content
Erschienen in: International Ophthalmology 8/2019

19.07.2018 | Original Paper

Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid

verfasst von: Tatsuya Yunoki, Akio Miyakoshi, Mitsuya Otsuka, Atsushi Hayashi

Erschienen in: International Ophthalmology | Ausgabe 8/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This study aimed to evaluate the relationships between androgen receptor (AR) expression and clinicopathologic features of sebaceous gland carcinoma (SGC) of the eyelid.

Methods

AR expression was evaluated via immunohistochemistry analysis of surgically derived samples from 11 patients with SGC of the eyelid.

Results

The expression of AR was evident in 9 of 11 patients (82%). We divided patients into high AR (7 patients) and low AR (4 patients: 2 patients with low expression and 2 patients with no expression) groups. The low AR group showed significantly greater progression than the high AR group with regard to T category and exhibited a lower grade of differentiation.

Conclusion

In patients with SGC of the eyelid, a marked decrease in AR expression may be associated with a poor prognosis. AR may be a prognostic factor and a potential therapeutic target in cases of SGC of the eyelid.
Literatur
1.
Zurück zum Zitat Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL (2004) Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 111:2151–2157CrossRefPubMed Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL (2004) Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 111:2151–2157CrossRefPubMed
2.
Zurück zum Zitat Takamura H, Yamashita H (2005) Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol 49:349–354CrossRefPubMed Takamura H, Yamashita H (2005) Clinicopathological analysis of malignant eyelid tumor cases at Yamagata university hospital: statistical comparison of tumor incidence in Japan and in other countries. Jpn J Ophthalmol 49:349–354CrossRefPubMed
3.
Zurück zum Zitat Leibovitch I, Selva D, Huilgol S, Davis G, Dodd T, James CL (2006) Intraepithelial sebaceous carcinoma of the eyelid misdiagnosed as Bowen’s disease. J Cutan Pathol 33:303–308CrossRefPubMed Leibovitch I, Selva D, Huilgol S, Davis G, Dodd T, James CL (2006) Intraepithelial sebaceous carcinoma of the eyelid misdiagnosed as Bowen’s disease. J Cutan Pathol 33:303–308CrossRefPubMed
4.
Zurück zum Zitat Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery lecture, part 1. Ophthalmology 111:997–1008CrossRefPubMed Shields JA, Shields CL, Scartozzi R (2004) Survey of 1264 patients with orbital tumors and simulating lesions: the 2002 Montgomery lecture, part 1. Ophthalmology 111:997–1008CrossRefPubMed
5.
Zurück zum Zitat Buitrago W, Joseph AK (2008) Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment. Dermatol Ther 21:459–466CrossRefPubMed Buitrago W, Joseph AK (2008) Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment. Dermatol Ther 21:459–466CrossRefPubMed
6.
Zurück zum Zitat Zürcher M, Hintschich CR, Garner A, Bunce C, Collin JR (1998) Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol 82:1049–1055CrossRefPubMedPubMedCentral Zürcher M, Hintschich CR, Garner A, Bunce C, Collin JR (1998) Sebaceous carcinoma of the eyelid: a clinicopathological study. Br J Ophthalmol 82:1049–1055CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL (2005) Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol 50:103–122CrossRefPubMed Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL (2005) Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol 50:103–122CrossRefPubMed
8.
Zurück zum Zitat Wolfe JT III, Yeatts RP, Wick MR, Campbell RJ, Waller RR (1984) Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol 8:597–606CrossRefPubMed Wolfe JT III, Yeatts RP, Wick MR, Campbell RJ, Waller RR (1984) Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol 8:597–606CrossRefPubMed
9.
Zurück zum Zitat Ansai S, Takeichi H, Arase S, Kawana S, Kimura T (2011) Sebaceous carcinoma: an immunohistochemical reappraisal. Am J Dermatopathol 33:579–587CrossRefPubMed Ansai S, Takeichi H, Arase S, Kawana S, Kimura T (2011) Sebaceous carcinoma: an immunohistochemical reappraisal. Am J Dermatopathol 33:579–587CrossRefPubMed
10.
Zurück zum Zitat Mulay K, Shah SJ, Aggarwal E, White VA, Honavar SG (2014) Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance? Acta Ophthalmol 92:e681–e687CrossRefPubMed Mulay K, Shah SJ, Aggarwal E, White VA, Honavar SG (2014) Periocular sebaceous gland carcinoma: do androgen receptor (NR3C4) and nuclear survivin (BIRC5) have a prognostic significance? Acta Ophthalmol 92:e681–e687CrossRefPubMed
11.
Zurück zum Zitat Jakobiec FA, Werdich X (2014) Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas. Am J Ophthalmol 157:687–696.e1-2CrossRefPubMed Jakobiec FA, Werdich X (2014) Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas. Am J Ophthalmol 157:687–696.e1-2CrossRefPubMed
12.
Zurück zum Zitat Mulay K, White VA, Shah SJ, Honavar SG (2014) Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Can J Ophthalmol 49:326–332CrossRefPubMed Mulay K, White VA, Shah SJ, Honavar SG (2014) Sebaceous carcinoma: clinicopathologic features and diagnostic role of immunohistochemistry (including androgen receptor). Can J Ophthalmol 49:326–332CrossRefPubMed
13.
Zurück zum Zitat Asadi-Amoli F, Khoshnevis F, Haeri H, Jahanzad I, Pazira R, Shahsiah R (2010) Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma. Am J Clin Pathol 134:22–26CrossRefPubMed Asadi-Amoli F, Khoshnevis F, Haeri H, Jahanzad I, Pazira R, Shahsiah R (2010) Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma. Am J Clin Pathol 134:22–26CrossRefPubMed
14.
Zurück zum Zitat Bayer-Garner IB, Givens V, Smoller B (1999) Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol 21:426–431CrossRefPubMed Bayer-Garner IB, Givens V, Smoller B (1999) Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation. Am J Dermatopathol 21:426–431CrossRefPubMed
15.
Zurück zum Zitat Cottle DL, Kretzschmar K, Schweiger PJ, Quist SR, Gollnick HP, Natsuga K, Aoyagi S, Watt FM (2013) c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis. Cell Rep 3:427–441CrossRefPubMedPubMedCentral Cottle DL, Kretzschmar K, Schweiger PJ, Quist SR, Gollnick HP, Natsuga K, Aoyagi S, Watt FM (2013) c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis. Cell Rep 3:427–441CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Na HY, Choe JY, Shin SA, Choung HK, Oh S, Chung JH, Park M, Kim JE (2016) Proposal of a provisional classification of sebaceous carcinoma based on hormone receptor expression and HER2 status. Am J Surg Pathol 40:1622–1630CrossRefPubMed Na HY, Choe JY, Shin SA, Choung HK, Oh S, Chung JH, Park M, Kim JE (2016) Proposal of a provisional classification of sebaceous carcinoma based on hormone receptor expression and HER2 status. Am J Surg Pathol 40:1622–1630CrossRefPubMed
17.
Zurück zum Zitat Amin MB, Edge SB, Greene FL et al (2017) AJCC cancer staging manual, 8th edn. Springer, New YorkCrossRef Amin MB, Edge SB, Greene FL et al (2017) AJCC cancer staging manual, 8th edn. Springer, New YorkCrossRef
18.
Zurück zum Zitat Takahashi Y, Takahashi E, Nakakura S, Kitaguchi Y, Mupas-Uy J, Kakizaki H (2016) Risk factors for local recurrence or metastasis of eyelid sebaceous gland carcinoma after wide excision with paraffin section control. Am J Ophthalmol 171:67–74CrossRefPubMed Takahashi Y, Takahashi E, Nakakura S, Kitaguchi Y, Mupas-Uy J, Kakizaki H (2016) Risk factors for local recurrence or metastasis of eyelid sebaceous gland carcinoma after wide excision with paraffin section control. Am J Ophthalmol 171:67–74CrossRefPubMed
19.
Zurück zum Zitat Izumi M, Mukai K, Nagai T, Matsubayashi J, Iwaya K, Chiu CS, Goto H (2008) Sebaceous carcinoma of the eyelids: thirty cases from Japan. Pathol Int 58:483–488CrossRefPubMed Izumi M, Mukai K, Nagai T, Matsubayashi J, Iwaya K, Chiu CS, Goto H (2008) Sebaceous carcinoma of the eyelids: thirty cases from Japan. Pathol Int 58:483–488CrossRefPubMed
20.
Zurück zum Zitat Watanabe A, Sun MT, Pirbhai A, Ueda K, Katori N, Selva D (2013) Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes. Br J Ophthalmol 97:1459–1463CrossRefPubMed Watanabe A, Sun MT, Pirbhai A, Ueda K, Katori N, Selva D (2013) Sebaceous carcinoma in Japanese patients: clinical presentation, staging and outcomes. Br J Ophthalmol 97:1459–1463CrossRefPubMed
21.
Zurück zum Zitat Choi YJ, Jin HC, Lee MJ, Kim N, Choung HK, Khwarg SI (2014) Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea. Jpn J Ophthalmol 58:327–333CrossRefPubMed Choi YJ, Jin HC, Lee MJ, Kim N, Choung HK, Khwarg SI (2014) Prognostic value of clinical and pathologic T stages defined by the American Joint Committee on Cancer for eyelid sebaceous carcinoma in Korea. Jpn J Ophthalmol 58:327–333CrossRefPubMed
22.
Zurück zum Zitat Esmaeli B, Nasser QJ, Cruz H, Fellman M, Warneke CL, Ivan D (2012) American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology 119:1078–1082CrossRefPubMed Esmaeli B, Nasser QJ, Cruz H, Fellman M, Warneke CL, Ivan D (2012) American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival. Ophthalmology 119:1078–1082CrossRefPubMed
23.
Zurück zum Zitat Muqit MM, Roberts F, Lee WR, Kemp E (2004) Improved survival rates in sebaceous carcinoma of the eyelid. Eye (Lond) 18:49–53CrossRef Muqit MM, Roberts F, Lee WR, Kemp E (2004) Improved survival rates in sebaceous carcinoma of the eyelid. Eye (Lond) 18:49–53CrossRef
24.
Zurück zum Zitat Shikata N, Kurokawa I, Andachi H, Tsubura A (1995) Expression of androgen receptors in skin appendage tumors: an immunohistochemical study. J Cutan Pathol 22:149–153CrossRefPubMed Shikata N, Kurokawa I, Andachi H, Tsubura A (1995) Expression of androgen receptors in skin appendage tumors: an immunohistochemical study. J Cutan Pathol 22:149–153CrossRefPubMed
25.
Zurück zum Zitat Chao AN, Shields CL, Krema H, Shields JA (2001) Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology 108:1877–1883CrossRefPubMed Chao AN, Shields CL, Krema H, Shields JA (2001) Outcome of patients with periocular sebaceous gland carcinoma with and without conjunctival intraepithelial invasion. Ophthalmology 108:1877–1883CrossRefPubMed
27.
Zurück zum Zitat Schmitz EJ, Herwig-Carl MC, Holz FG, Loeffler KU (2017) Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns. Graefes Arch Clin Exp Ophthalmol 255:2277–2285CrossRefPubMed Schmitz EJ, Herwig-Carl MC, Holz FG, Loeffler KU (2017) Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns. Graefes Arch Clin Exp Ophthalmol 255:2277–2285CrossRefPubMed
Metadaten
Titel
Clinicopathological features of considerable reduction in androgen receptor expression in sebaceous gland carcinoma of the eyelid
verfasst von
Tatsuya Yunoki
Akio Miyakoshi
Mitsuya Otsuka
Atsushi Hayashi
Publikationsdatum
19.07.2018
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 8/2019
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-018-0990-3

Weitere Artikel der Ausgabe 8/2019

International Ophthalmology 8/2019 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.